NU665 Week 8 Midterm Exam
Regis College | Psychiatric-Mental Health Nurse Practitioner (PMHNP) Curriculum
120 Questions • Comprehensive Rationales Provided • Aligned with PMHNP-BC / ANCC
& AANP Certification Standards
Instructions: This examination consists of 120 multiple-choice questions distributed across eight (8) integrated content
domains. Each question has one (1) best answer. Select the single most appropriate response. Detailed clinical rationales
accompany each answer key. Cognitive level distribution: 25% recall, 55% application, 20% analysis. Format: 75%
scenario-based, 25% direct recall. Estimated completion time: 180 minutes.
Section 1: Neurobiology and Neuroanatomy of Psychiatric Disorders
| Q1 – Q18
Q1.
A 24-year-old female graduate student presents with new-onset panic attacks, hyper vigilance, and insomnia
following a sexual assault three months ago. Neuroimaging reveals hyperreactivity in a structure that consolidates
fear memories and projects to the hypothalamus to activate the sympathetic nervous system. Which brain structure is
most likely responsible for her exaggerated fear response?
A. Hippocampus
B. Amygdala [CORRECT]
C. Prefrontal cortex
D. Cerebellum
Correct Answer: B. Amygdala
Rationale:
The amygdala is the primary neural substrate for fear conditioning, threat detection, and emotional memory
consolidation. In PTSD, the amygdala becomes hyperreactive, driving exaggerated fear responses and autonomic
arousal via projections to the hypothalamus (activating the sympathetic nervous system) and brainstem nuclei. The
hippocampus (option A) is primarily responsible for declarative memory and contextual learning; in PTSD it is often
hyporeactive, impairing contextualization of threat. The prefrontal cortex (option C) exerts top-down inhibitory control
over the amygdala and is hypoactive in PTSD, but it does not generate the fear response itself. The cerebellum (option
D) coordinates motor function and has a minor role in cognitive-affective processing but is not implicated in acute fear
circuitry.
Q2.
Page 1
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
,Regis College NU665 Week 8 Midterm Exam — PMHNP Curriculum Confidential — Academic Use Only
A PMHNP is educating a patient about the neurobiological basis of depression. The patient asks which brain region,
when hypoactive, contributes to the cognitive symptoms of depression such as poor concentration, executive
dysfunction, and impaired decision-making. Which structure is the most accurate response?
A. Hippocampus
B. Dorsolateral prefrontal cortex [CORRECT]
C. Cerebellar vermis
D. Primary visual cortex
Correct Answer: B. Dorsolateral prefrontal cortex
Rationale:
The dorsolateral prefrontal cortex (DLPFC) governs executive functions including working memory, attention,
cognitive flexibility, and decision-making. Hypoactivity in the DLPFC on functional imaging is a hallmark of major
depressive disorder and correlates with the cognitive symptoms of depression (poor concentration, indecisiveness,
executive dysfunction). The hippocampus (option A) is involved in memory consolidation and shows volume loss in
chronic depression, but it does not primarily mediate executive function. The cerebellar vermis (option C) is involved in
motor coordination and vestibular function with some affective modulation, but it is not the primary site of executive
dysfunction. The primary visual cortex (option D) processes visual input and is not implicated in depressive cognitive
symptoms.
Q3.
A patient with treatment-resistant depression is started on an augmentation strategy. The PMHNP explains that the
medication targets a neurotransmitter synthesized primarily in the raphe nuclei. Which neurotransmitter is being
described?
A. Dopamine
B. Norepinephrine
C. Serotonin [CORRECT]
D. Glutamate
Correct Answer: C. Serotonin
Rationale:
Serotonin (5-hydroxytryptamine, 5-HT) is synthesized primarily in the raphe nuclei located along the midline of the
brainstem, with widespread projections to virtually all CNS regions including the cortex, limbic system, and spinal
cord. SSRIs and SNRIs work by blocking reuptake of serotonin, increasing synaptic availability. Dopamine (option A)
is synthesized primarily in the substantia nigra and ventral tegmental area (VTA). Norepinephrine (option B) is
synthesized in the locus coeruleus. Glutamate (option D) is the primary excitatory neurotransmitter and is synthesized
throughout the CNS by multiple neuronal populations rather than a single discrete nucleus.
Q4.
A 35-year-old male with bipolar I disorder is experiencing an acute manic episode characterized by grandiosity,
decreased need for sleep, and increased goal-directed activity. Neurobiologically, this presentation is most associated
with dysregulation in which neurotransmitter pathway?
A. Excessive serotonin in the raphe nuclei
B. Excessive dopamine activity in the mesolimbic pathway [CORRECT]
C. Deficient GABA in the thalamus
D. Deficient acetylcholine in the basal forebrain
Correct Answer: B. Excessive dopamine activity in the mesolimbic pathway
Page 2
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
,Regis College NU665 Week 8 Midterm Exam — PMHNP Curriculum Confidential — Academic Use Only
Rationale:
Mania is most closely associated with excessive dopaminergic activity in the mesolimbic pathway, which connects the
ventral tegmental area (VTA) to the nucleus accumbens and is central to reward, motivation, and goal-directed
behavior. This explains key manic symptoms such as grandiosity, hyperactivity, and increased reward-seeking.
Antipsychotics used in acute mania work largely by blocking D2 receptors in this pathway. While serotonin
dysregulation (option A) is implicated in mood disorders broadly, it is not the primary driver of manic euphoria. GABA
deficiency (option C) may contribute to anxiety and seizure threshold but not the hallmark manic presentation.
Acetylcholine deficits (option D) are associated with cognitive decline (e.g., Alzheimer's), not mania.
Q5.
A PMHNP is reviewing the neurobiology of addiction with a student. The student correctly identifies that the brain's
primary reward circuitry—the mesolimbic dopamine pathway—projects from the ventral tegmental area to which
target structure?
A. Substantia nigra
B. Locus coeruleus
C. Nucleus accumbens [CORRECT]
D. Hippocampus
Correct Answer: C. Nucleus accumbens
Rationale:
The mesolimbic dopamine pathway originates in the ventral tegmental area (VTA) and projects to the nucleus
accumbens, which is the central component of the brain's reward circuitry. This pathway mediates the reinforcing
effects of natural rewards (food, sex, social interaction) as well as substances of abuse, which all ultimately increase
dopamine release in the nucleus accumbens. The substantia nigra (option A) is part of the nigrostriatal pathway
involved in motor control. The locus coeruleus (option B) is the primary site of norepinephrine synthesis and is
involved in arousal and stress response. The hippocampus (option D) is involved in memory consolidation, not primary
reward processing.
Q6.
A 42-year-old male with schizophrenia exhibits predominantly negative symptoms including blunted affect, alogia,
and avolition. Research suggests these symptoms are most associated with hypoactivity of dopamine in which
pathway?
A. Mesolimbic pathway
B. Mesocortical pathway [CORRECT]
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Correct Answer: B. Mesocortical pathway
Rationale:
The mesocortical pathway projects from the ventral tegmental area to the prefrontal cortex and is hypothesized to be
hypoactive in schizophrenia, contributing to negative symptoms (blunted affect, alogia, avolition, anhedonia) and
cognitive symptoms. This is in contrast to the mesolimbic pathway (option A), which is hyperactive and produces
positive symptoms (hallucinations, delusions). The nigrostriatal pathway (option C) is involved in motor control;
blockade there by antipsychotics causes extrapyramidal symptoms. The tuberoinfundibular pathway (option D)
regulates prolactin secretion; its blockade causes hyperprolactinemia. This dual dopamine hypothesis (mesolimbic
hyperactivity + mesocortical hypoactivity) explains why antipsychotics can reduce positive symptoms but often worsen
or fail to improve negative symptoms.
Page 3
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
, Regis College NU665 Week 8 Midterm Exam — PMHNP Curriculum Confidential — Academic Use Only
Q7.
A 28-year-old female with generalized anxiety disorder has excessive worry, muscle tension, and autonomic
hyperarousal. The PMHNP understands that hyperactivity of the locus coeruleus contributes to her symptoms. Which
neurotransmitter does the locus coeruleus primarily produce?
A. Dopamine
B. Norepinephrine [CORRECT]
C. Serotonin
D. GABA
Correct Answer: B. Norepinephrine
Rationale:
The locus coeruleus, located in the pons, is the primary site of norepinephrine synthesis in the central nervous system
and projects widely throughout the brain. Hyperactivity of the locus coeruleus produces the autonomic arousal
symptoms characteristic of anxiety disorders, including tachycardia, sweating, tremor, hypervigilance, and the
physiological components of panic. Medications such as SNRIs and pregabalin reduce anxiety partly by modulating
noradrenergic transmission. Dopamine (option A) is produced in the substantia nigra and VTA. Serotonin (option C) is
produced in the raphe nuclei. GABA (option D) is the primary inhibitory neurotransmitter, produced by interneurons
throughout the CNS rather than a single discrete nucleus.
Q8.
A 19-year-old male with new-onset psychosis is being evaluated. The PMHNP orders a comprehensive metabolic
panel, TSH, urinary drug screen, and MRI of the brain before establishing a primary psychiatric diagnosis. The
primary rationale for this workup is to:
A. Confirm the diagnosis of schizophrenia
B. Rule out organic causes of psychiatric symptoms before psychiatric treatment [CORRECT]
C. Determine which antipsychotic will be most effective
D. Establish a baseline for future laboratory monitoring
Correct Answer: B. Rule out organic causes of psychiatric symptoms before psychiatric treatment
Rationale:
The standard of care for any new-onset psychiatric presentation is to first rule out organic causes (medication-induced,
substance-induced, metabolic, endocrine, infectious, or structural lesions) before attributing symptoms to a primary
psychiatric disorder. This is essential because organic conditions such as thyroid dysfunction, B12 deficiency,
autoimmune encephalitis, brain tumors, or substance intoxication can present with psychiatric symptoms and require
medical rather than psychiatric treatment. While baseline labs (option D) are important for monitoring, that is a
secondary benefit. The workup cannot confirm schizophrenia (option A); diagnosis is clinical and requires six months
of symptoms. The workup does not determine antipsychotic selection (option C); that is based on symptom profile,
side-effect profile, and patient factors.
Q9.
Page 4
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
Regis College | Psychiatric-Mental Health Nurse Practitioner (PMHNP) Curriculum
120 Questions • Comprehensive Rationales Provided • Aligned with PMHNP-BC / ANCC
& AANP Certification Standards
Instructions: This examination consists of 120 multiple-choice questions distributed across eight (8) integrated content
domains. Each question has one (1) best answer. Select the single most appropriate response. Detailed clinical rationales
accompany each answer key. Cognitive level distribution: 25% recall, 55% application, 20% analysis. Format: 75%
scenario-based, 25% direct recall. Estimated completion time: 180 minutes.
Section 1: Neurobiology and Neuroanatomy of Psychiatric Disorders
| Q1 – Q18
Q1.
A 24-year-old female graduate student presents with new-onset panic attacks, hyper vigilance, and insomnia
following a sexual assault three months ago. Neuroimaging reveals hyperreactivity in a structure that consolidates
fear memories and projects to the hypothalamus to activate the sympathetic nervous system. Which brain structure is
most likely responsible for her exaggerated fear response?
A. Hippocampus
B. Amygdala [CORRECT]
C. Prefrontal cortex
D. Cerebellum
Correct Answer: B. Amygdala
Rationale:
The amygdala is the primary neural substrate for fear conditioning, threat detection, and emotional memory
consolidation. In PTSD, the amygdala becomes hyperreactive, driving exaggerated fear responses and autonomic
arousal via projections to the hypothalamus (activating the sympathetic nervous system) and brainstem nuclei. The
hippocampus (option A) is primarily responsible for declarative memory and contextual learning; in PTSD it is often
hyporeactive, impairing contextualization of threat. The prefrontal cortex (option C) exerts top-down inhibitory control
over the amygdala and is hypoactive in PTSD, but it does not generate the fear response itself. The cerebellum (option
D) coordinates motor function and has a minor role in cognitive-affective processing but is not implicated in acute fear
circuitry.
Q2.
Page 1
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
,Regis College NU665 Week 8 Midterm Exam — PMHNP Curriculum Confidential — Academic Use Only
A PMHNP is educating a patient about the neurobiological basis of depression. The patient asks which brain region,
when hypoactive, contributes to the cognitive symptoms of depression such as poor concentration, executive
dysfunction, and impaired decision-making. Which structure is the most accurate response?
A. Hippocampus
B. Dorsolateral prefrontal cortex [CORRECT]
C. Cerebellar vermis
D. Primary visual cortex
Correct Answer: B. Dorsolateral prefrontal cortex
Rationale:
The dorsolateral prefrontal cortex (DLPFC) governs executive functions including working memory, attention,
cognitive flexibility, and decision-making. Hypoactivity in the DLPFC on functional imaging is a hallmark of major
depressive disorder and correlates with the cognitive symptoms of depression (poor concentration, indecisiveness,
executive dysfunction). The hippocampus (option A) is involved in memory consolidation and shows volume loss in
chronic depression, but it does not primarily mediate executive function. The cerebellar vermis (option C) is involved in
motor coordination and vestibular function with some affective modulation, but it is not the primary site of executive
dysfunction. The primary visual cortex (option D) processes visual input and is not implicated in depressive cognitive
symptoms.
Q3.
A patient with treatment-resistant depression is started on an augmentation strategy. The PMHNP explains that the
medication targets a neurotransmitter synthesized primarily in the raphe nuclei. Which neurotransmitter is being
described?
A. Dopamine
B. Norepinephrine
C. Serotonin [CORRECT]
D. Glutamate
Correct Answer: C. Serotonin
Rationale:
Serotonin (5-hydroxytryptamine, 5-HT) is synthesized primarily in the raphe nuclei located along the midline of the
brainstem, with widespread projections to virtually all CNS regions including the cortex, limbic system, and spinal
cord. SSRIs and SNRIs work by blocking reuptake of serotonin, increasing synaptic availability. Dopamine (option A)
is synthesized primarily in the substantia nigra and ventral tegmental area (VTA). Norepinephrine (option B) is
synthesized in the locus coeruleus. Glutamate (option D) is the primary excitatory neurotransmitter and is synthesized
throughout the CNS by multiple neuronal populations rather than a single discrete nucleus.
Q4.
A 35-year-old male with bipolar I disorder is experiencing an acute manic episode characterized by grandiosity,
decreased need for sleep, and increased goal-directed activity. Neurobiologically, this presentation is most associated
with dysregulation in which neurotransmitter pathway?
A. Excessive serotonin in the raphe nuclei
B. Excessive dopamine activity in the mesolimbic pathway [CORRECT]
C. Deficient GABA in the thalamus
D. Deficient acetylcholine in the basal forebrain
Correct Answer: B. Excessive dopamine activity in the mesolimbic pathway
Page 2
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
,Regis College NU665 Week 8 Midterm Exam — PMHNP Curriculum Confidential — Academic Use Only
Rationale:
Mania is most closely associated with excessive dopaminergic activity in the mesolimbic pathway, which connects the
ventral tegmental area (VTA) to the nucleus accumbens and is central to reward, motivation, and goal-directed
behavior. This explains key manic symptoms such as grandiosity, hyperactivity, and increased reward-seeking.
Antipsychotics used in acute mania work largely by blocking D2 receptors in this pathway. While serotonin
dysregulation (option A) is implicated in mood disorders broadly, it is not the primary driver of manic euphoria. GABA
deficiency (option C) may contribute to anxiety and seizure threshold but not the hallmark manic presentation.
Acetylcholine deficits (option D) are associated with cognitive decline (e.g., Alzheimer's), not mania.
Q5.
A PMHNP is reviewing the neurobiology of addiction with a student. The student correctly identifies that the brain's
primary reward circuitry—the mesolimbic dopamine pathway—projects from the ventral tegmental area to which
target structure?
A. Substantia nigra
B. Locus coeruleus
C. Nucleus accumbens [CORRECT]
D. Hippocampus
Correct Answer: C. Nucleus accumbens
Rationale:
The mesolimbic dopamine pathway originates in the ventral tegmental area (VTA) and projects to the nucleus
accumbens, which is the central component of the brain's reward circuitry. This pathway mediates the reinforcing
effects of natural rewards (food, sex, social interaction) as well as substances of abuse, which all ultimately increase
dopamine release in the nucleus accumbens. The substantia nigra (option A) is part of the nigrostriatal pathway
involved in motor control. The locus coeruleus (option B) is the primary site of norepinephrine synthesis and is
involved in arousal and stress response. The hippocampus (option D) is involved in memory consolidation, not primary
reward processing.
Q6.
A 42-year-old male with schizophrenia exhibits predominantly negative symptoms including blunted affect, alogia,
and avolition. Research suggests these symptoms are most associated with hypoactivity of dopamine in which
pathway?
A. Mesolimbic pathway
B. Mesocortical pathway [CORRECT]
C. Nigrostriatal pathway
D. Tuberoinfundibular pathway
Correct Answer: B. Mesocortical pathway
Rationale:
The mesocortical pathway projects from the ventral tegmental area to the prefrontal cortex and is hypothesized to be
hypoactive in schizophrenia, contributing to negative symptoms (blunted affect, alogia, avolition, anhedonia) and
cognitive symptoms. This is in contrast to the mesolimbic pathway (option A), which is hyperactive and produces
positive symptoms (hallucinations, delusions). The nigrostriatal pathway (option C) is involved in motor control;
blockade there by antipsychotics causes extrapyramidal symptoms. The tuberoinfundibular pathway (option D)
regulates prolactin secretion; its blockade causes hyperprolactinemia. This dual dopamine hypothesis (mesolimbic
hyperactivity + mesocortical hypoactivity) explains why antipsychotics can reduce positive symptoms but often worsen
or fail to improve negative symptoms.
Page 3
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
, Regis College NU665 Week 8 Midterm Exam — PMHNP Curriculum Confidential — Academic Use Only
Q7.
A 28-year-old female with generalized anxiety disorder has excessive worry, muscle tension, and autonomic
hyperarousal. The PMHNP understands that hyperactivity of the locus coeruleus contributes to her symptoms. Which
neurotransmitter does the locus coeruleus primarily produce?
A. Dopamine
B. Norepinephrine [CORRECT]
C. Serotonin
D. GABA
Correct Answer: B. Norepinephrine
Rationale:
The locus coeruleus, located in the pons, is the primary site of norepinephrine synthesis in the central nervous system
and projects widely throughout the brain. Hyperactivity of the locus coeruleus produces the autonomic arousal
symptoms characteristic of anxiety disorders, including tachycardia, sweating, tremor, hypervigilance, and the
physiological components of panic. Medications such as SNRIs and pregabalin reduce anxiety partly by modulating
noradrenergic transmission. Dopamine (option A) is produced in the substantia nigra and VTA. Serotonin (option C) is
produced in the raphe nuclei. GABA (option D) is the primary inhibitory neurotransmitter, produced by interneurons
throughout the CNS rather than a single discrete nucleus.
Q8.
A 19-year-old male with new-onset psychosis is being evaluated. The PMHNP orders a comprehensive metabolic
panel, TSH, urinary drug screen, and MRI of the brain before establishing a primary psychiatric diagnosis. The
primary rationale for this workup is to:
A. Confirm the diagnosis of schizophrenia
B. Rule out organic causes of psychiatric symptoms before psychiatric treatment [CORRECT]
C. Determine which antipsychotic will be most effective
D. Establish a baseline for future laboratory monitoring
Correct Answer: B. Rule out organic causes of psychiatric symptoms before psychiatric treatment
Rationale:
The standard of care for any new-onset psychiatric presentation is to first rule out organic causes (medication-induced,
substance-induced, metabolic, endocrine, infectious, or structural lesions) before attributing symptoms to a primary
psychiatric disorder. This is essential because organic conditions such as thyroid dysfunction, B12 deficiency,
autoimmune encephalitis, brain tumors, or substance intoxication can present with psychiatric symptoms and require
medical rather than psychiatric treatment. While baseline labs (option D) are important for monitoring, that is a
secondary benefit. The workup cannot confirm schizophrenia (option A); diagnosis is clinical and requires six months
of symptoms. The workup does not determine antipsychotic selection (option C); that is based on symptom profile,
side-effect profile, and patient factors.
Q9.
Page 4
Aligned with PMHNP-BC / ANCC & AANP Certification Standards
